Effect of monoamine oxidase inhibition on rewarding effects of nicotine in rodents

Christine H. Kapelewski, David John Vandenbergh, Laura Klein

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Nicotine, the primary psychoactive compound in tobacco, is responsible for the addictive effects of smoking; however, there is a paucity of information indicating whether the presence of other biological chemicals in tobacco alters nicotine's rewarding effects. It has been suggested that the addictive effects of smoking may be due, in part, to the inhibition of the pair of monoamine oxidase enzymes responsible for a significant fraction of monoamine metabolism, Monoamine Oxidase A and B (MAO-A and MAO-B). This paper reviews the current, limited literature examining the role of MAO inhibition on the rewarding effects of nicotine (e.g., self-administration) in rodents. Overall, studies with rats and mice do suggest that MAO plays a role in nicotine reward. However, results are mixed regarding the MAO subtype responsible for the rewarding effects of nicotine, most likely due to methodological variation across the limited number of studies. Important individual difference factors such as age, sex and genetics are discussed, along with relevant brain and neurotransmitter systems. Future research is needed that builds on the available literature to map out the relationship between MAO inhibition and nicotine reward. These data will enhance our understanding of the neuropharmacological effects of smoking and the value of implementing MAO inhibitors as pharmacotherapies for smoking cessation.

Original languageEnglish (US)
Pages (from-to)110-121
Number of pages12
JournalCurrent Drug Abuse Reviews
Volume4
Issue number2
StatePublished - Jun 1 2011

Fingerprint

Monoamine Oxidase
Nicotine
Rodentia
Smoking
Reward
Tobacco
Inhibition (Psychology)
Monoamine Oxidase Inhibitors
Self Administration
Smoking Cessation
Individuality
Neurotransmitter Agents
Drug Therapy
Brain
Enzymes

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

@article{f2d25c9db92147038ca3e55d4c2e0557,
title = "Effect of monoamine oxidase inhibition on rewarding effects of nicotine in rodents",
abstract = "Nicotine, the primary psychoactive compound in tobacco, is responsible for the addictive effects of smoking; however, there is a paucity of information indicating whether the presence of other biological chemicals in tobacco alters nicotine's rewarding effects. It has been suggested that the addictive effects of smoking may be due, in part, to the inhibition of the pair of monoamine oxidase enzymes responsible for a significant fraction of monoamine metabolism, Monoamine Oxidase A and B (MAO-A and MAO-B). This paper reviews the current, limited literature examining the role of MAO inhibition on the rewarding effects of nicotine (e.g., self-administration) in rodents. Overall, studies with rats and mice do suggest that MAO plays a role in nicotine reward. However, results are mixed regarding the MAO subtype responsible for the rewarding effects of nicotine, most likely due to methodological variation across the limited number of studies. Important individual difference factors such as age, sex and genetics are discussed, along with relevant brain and neurotransmitter systems. Future research is needed that builds on the available literature to map out the relationship between MAO inhibition and nicotine reward. These data will enhance our understanding of the neuropharmacological effects of smoking and the value of implementing MAO inhibitors as pharmacotherapies for smoking cessation.",
author = "Kapelewski, {Christine H.} and Vandenbergh, {David John} and Laura Klein",
year = "2011",
month = "6",
day = "1",
language = "English (US)",
volume = "4",
pages = "110--121",
journal = "Current Drug Research Reviews",
issn = "2589-9775",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

Effect of monoamine oxidase inhibition on rewarding effects of nicotine in rodents. / Kapelewski, Christine H.; Vandenbergh, David John; Klein, Laura.

In: Current Drug Abuse Reviews, Vol. 4, No. 2, 01.06.2011, p. 110-121.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of monoamine oxidase inhibition on rewarding effects of nicotine in rodents

AU - Kapelewski, Christine H.

AU - Vandenbergh, David John

AU - Klein, Laura

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Nicotine, the primary psychoactive compound in tobacco, is responsible for the addictive effects of smoking; however, there is a paucity of information indicating whether the presence of other biological chemicals in tobacco alters nicotine's rewarding effects. It has been suggested that the addictive effects of smoking may be due, in part, to the inhibition of the pair of monoamine oxidase enzymes responsible for a significant fraction of monoamine metabolism, Monoamine Oxidase A and B (MAO-A and MAO-B). This paper reviews the current, limited literature examining the role of MAO inhibition on the rewarding effects of nicotine (e.g., self-administration) in rodents. Overall, studies with rats and mice do suggest that MAO plays a role in nicotine reward. However, results are mixed regarding the MAO subtype responsible for the rewarding effects of nicotine, most likely due to methodological variation across the limited number of studies. Important individual difference factors such as age, sex and genetics are discussed, along with relevant brain and neurotransmitter systems. Future research is needed that builds on the available literature to map out the relationship between MAO inhibition and nicotine reward. These data will enhance our understanding of the neuropharmacological effects of smoking and the value of implementing MAO inhibitors as pharmacotherapies for smoking cessation.

AB - Nicotine, the primary psychoactive compound in tobacco, is responsible for the addictive effects of smoking; however, there is a paucity of information indicating whether the presence of other biological chemicals in tobacco alters nicotine's rewarding effects. It has been suggested that the addictive effects of smoking may be due, in part, to the inhibition of the pair of monoamine oxidase enzymes responsible for a significant fraction of monoamine metabolism, Monoamine Oxidase A and B (MAO-A and MAO-B). This paper reviews the current, limited literature examining the role of MAO inhibition on the rewarding effects of nicotine (e.g., self-administration) in rodents. Overall, studies with rats and mice do suggest that MAO plays a role in nicotine reward. However, results are mixed regarding the MAO subtype responsible for the rewarding effects of nicotine, most likely due to methodological variation across the limited number of studies. Important individual difference factors such as age, sex and genetics are discussed, along with relevant brain and neurotransmitter systems. Future research is needed that builds on the available literature to map out the relationship between MAO inhibition and nicotine reward. These data will enhance our understanding of the neuropharmacological effects of smoking and the value of implementing MAO inhibitors as pharmacotherapies for smoking cessation.

UR - http://www.scopus.com/inward/record.url?scp=79960600850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960600850&partnerID=8YFLogxK

M3 - Article

C2 - 21696345

AN - SCOPUS:79960600850

VL - 4

SP - 110

EP - 121

JO - Current Drug Research Reviews

JF - Current Drug Research Reviews

SN - 2589-9775

IS - 2

ER -